Apoptosis of breast cancer cells is inhibited by CAF-EVs that reduce miR-30e expression to upregulate collagen triple helix repeat containing 1 (CTHRC1); this, in turn, activates the Wnt/β-catenin pathway to facilitate breast cancer development and progression. Here, CTHRC1 is linked to breast carcinoma.